EDGAR·FLOW

Burning Rock Biotech Ltd — Form 4

Filed July 2, 2026 · analyzed by the Insider Agent
4 ▲ Likely positive significance 68/100
What the filing says
Director Han Yusheng (BNR) bought 731K shares (~$6.2M) on the open market (3.8% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating

Open-market insider purchase — historically a bullish signal.

View original filing on SEC.gov ↗

See more from July 2, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.